Search Results - "Buesche, G" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

by Mossner, M, Jann, J-C, Nowak, D, Platzbecker, U, Giagounidis, A, Götze, K, Letsch, A, Haase, D, Shirneshan, K, Braulke, F, Schlenk, R F, Haferlach, T, Schafhausen, P, Bug, G, Lübbert, M, Ganser, A, Büsche, G, Schuler, E, Nowak, V, Pressler, J, Obländer, J, Fey, S, Müller, N, Lauinger-Lörsch, E, Metzgeroth, G, Weiß, C, Hofmann, W-K, Germing, U, Nolte, F
Published in Leukemia (01.09.2016)

Get full text

Journal Article

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

by Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R
Published in Leukemia (01.03.2016)

Get full text

Journal Article

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

by Schuler, E, Giagounidis, A, Haase, D, Shirneshan, K, Büsche, G, Platzbecker, U, Nolte, F, Götze, K, Schlenk, R F, Ganser, A, Letsch, A, Braulke, F, Lübbert, M, Bug, G, Schafhausen, P, Bacher, U, Gattermann, N, Wulfert, M, Haas, R, Germing, U
Published in Leukemia (01.07.2016)

Get full text

Journal Article

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

by Bartels, S, Lehmann, U, Büsche, G, Schlue, J, Mozer, M, Stadler, J, Triviai, I, Alchalby, H, Kröger, N, Kreipe, H
Published in Leukemia (01.01.2015)

Get full text

Journal Article

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes

by Buesche, G, Teoman, H, Wilczak, W, Ganser, A, Hecker, H, Wilkens, L, Göhring, G, Schlegelberger, B, Bock, O, Georgii, A, Kreipe, H
Published in Leukemia (01.02.2008)

Get full text

Journal Article

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia

by BUESCHE, G, GANSER, A, SCHLEGELBERGER, B, VON NEUHOFF, N, GADZICKI, D, HECKER, H, BOCK, O, FRYE, B, KREIPE, H
Published in Leukemia (01.12.2007)

Get full text

Journal Article

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

by Göhring, G, Lange, K, Hofmann, W, Nielsen, K V, Hellström-Lindberg, E, Roy, L, Morgan, M, Kreipe, H, Büsche, G, Giagounidis, A, Schlegelberger, B
Published in Leukemia (01.02.2012)

Get full text

Journal Article

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas

by Wolf, S, Rudolph, C, Morgan, M, Büsche, G, Salguero, G, Stripecke, R, Schlegelberger, B, Baum, C, Modlich, U
Published in Oncogene (20.06.2013)

Get full text

Journal Article

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells

by Pincha, M, Salguero, G, Wedekind, D, Sundarasetty, B S, Lin, A, Kasahara, N, Brugman, M H, Jirmo, A C, Modlich, U, Gutzmer, R, Büsche, G, Ganser, A, Stripecke, R
Published in Gene therapy (01.08.2011)

Get full text

Journal Article

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

by Hussein, K, Horny, H-P, Büsche, G, Görner, M, Göhring, G, Kreipe, H, Bock, O
Published in Leukemia (01.06.2011)

Get full text

Journal Article

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial

by BUESCHE, G, HEHLMANN, R, KAPPLER, M, HASFORD, J, BUHR, T, KREIPE, H-H, GEORGII, A, HECKER, H, HEIMPEL, H, HEINZE, B, SCHMEIL, A, PFIRRMANN, M, GOMEZ, G, TOBLER, A, HERRMANN, H
Published in Leukemia (01.12.2003)

Get full text

Journal Article

P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide

P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide

by Buesche, G, Giagounidis, A, Bock, O, Teoman, H, Göhring, G, Schlegelberger, B, Dieck, S, Ganser, A, List, A, Bennett, J.M, Aul, C, Kreipe, H.H
Published in Leukemia research (01.05.2013)

Get full text

Journal Article

P-239 Telomere length of granulocytes significantly increases during the first six months of lenalidomide treatment in patients with isolated 5q- syndrome

P-239 Telomere length of granulocytes significantly increases during the first six months of lenalidomide treatment in patients with isolated 5q- syndrome

by Beier, F, Germing, U, Buesche, G, Ziegler, P, Wilop, S, Vankann, L, Gattermann, N, Platzbecker, U, Giagounidis, A, Götze, K, Hofmann, W.K, Haase, D, Kreipe, H, Panse, J, Brümmendorf, T.H
Published in Leukemia research (01.05.2013)

Get full text

Journal Article

269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality

269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality

by Buesche, G, Giagounidis, A, Göhring, G, Schlegelberger, B, Dieck, S, Knight, R, Aul, C, Kreipe, H
Published in Leukemia research (2011)

Get full text

Journal Article

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies

by Buesche, G, Georgii, A, Kreipe, H-H
Published in Histopathology (01.01.2006)

Get full text

Journal Article

Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies

Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies

by Georgii, A, Buhr, T, Buesche, G, Kreft, A, Choritz, H
Published in Leukemia & lymphoma (01.01.1996)

Get more information

Journal Article

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2

by Bartels, S, Faisal, M, Büsche, G, Schlue, J, Kreipe, H, Lehmann, U
Published in Leukemia (01.02.2018)

Get full text

Journal Article

RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms

RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms

by Faisal, M., Büsche, G., Schlue, J., Kreipe, H., Lehmann, U., Bartels, S.
Published in Annals of hematology (01.05.2019)

Get full text

Journal Article

Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm

Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm

by Bartels, S., Lehmann, U., Büsche, G., Schlue, J., Kreipe, H.
Published in Annals of hematology (01.08.2016)

Get full text

Journal Article

Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes

Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes

by Buesche, Guntram, Teoman, Huesniye, Giagounidis, Aristoteles, Göhring, Gudrun, Schlegelberger, Brigitte, Ganser, Arnold, Aul, Carlo, Kreipe, Hans-Heinrich
Published in Haematologica (Roma) (01.05.2016)

Get full text

Journal Article